SHARE
COPY LINK

AID

Denmark offers companies $6bn in coronavirus cash hand-outs

Denmark's finance ministry has announced plans to spend up to 40bn Danish kroner ($6bn) to help companies hit by the coronavirus crisis to cover their fixed costs until cash flow resumes.

Denmark offers companies $6bn in coronavirus cash hand-outs
Nicolai Wammen arrives for the press conference on Wednesday. Photo: Niels Christian Vilmann/Ritzau Scanpix
Under the scheme, companies who have seen their revenues decline by 40 percent or more, will receive government grants to help cover between 25 to 80 percent of their fixed costs. 
 
The self-employed and firms with up to ten people who see their revenues fall more than 30 percent will also be offered government compensation worth 75 percent of their normal monthly income — up to a maximum of 23,000-a-month. 
 
The two grants will be available for three months, after which the hope is that the economy will be able to return to normal. 
 
“These are measures that have never been seen before. It is extraordinary,” Finance Minister Nicolai Wammen said as he announced the measures, according to the public broadcaster DR.  “We are not talking about loans. These are cash hand-outs.” 
 
The two measures come on top of the government's decision to defer as much as 125bn Danish kroner of companies' tax and VAT payments, and its decision to pay between 75 percent and 90 percent of the salaries of employees businesses send home during the crisis. 
 
It has also released banks' countercyclical capital buffer, freeing up 17bn kroner in potential liquidity. 
 
The latest measure has been welcomed by business, but has drawn criticism from some economists. 
 
“It's almost completely crazy that a Danish government can just spend 40bn kroner without any further investigation or much debate,” said Las Olsen, the chief economist at Danske Bank, told Denmark's Jyllands-Posten
 
“These are completely unheard of steps that the government is now taking,” Helge J. Pedersen, chief economist at Nordea, told the magazine. “This is significantly more than fiscal policy was expanded during the 2008-09 financial crisis.” 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS